Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 6.37
- Piotroski Score 7.00
- Grade Underweight
- Symbol (A)
- Company Agilent Technologies, Inc.
- Price $148.15
- Changes Percentage (0.96%)
- Change $1.41
- Day Low $147.18
- Day High $150.08
- Year High $155.35
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
- Last Earnings 09/18/2024
- Ex-Dividend for 5/16 Dividend 10/01/2024
- Dividend Payable 10/23/2024
- Today N/A
- Next Earnings (Estimated) 11/17/2024
- Fiscal Year End N/A
- Average Stock Price Target $146.00
- High Stock Price Target $170.00
- Low Stock Price Target $105.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $4.22
- Trailing P/E Ratio 31.51
- Forward P/E Ratio 31.51
- P/E Growth 31.51
- Net Income $1.24 B
Income Statement
Quarterly
Annual
Latest News of A
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
AppLovin (NASDAQ:APP) Stock Skyrockets 242% on Growth and AI Potential
AppLovin stock has soared due to robust earnings, tech sector growth, and upgrades. The company offers mobile tech solutions for app monetization. Key factors driving success include AI-driven adverti...
By Yahoo! Finance | 3 hours ago -
Iger's succession 'top of mind' for investors: Analyst
Macquarie's Tim Nollen discusses Disney's future post-CEO Bob Iger's contract expiration in 2026. Nollen believes Iger has done well at Disney and suggests a stable time for transition in two years as...
By Yahoo! Finance | 3 hours ago -
Bausch Health Companies Inc. (BHC): A Top Pick in Carl Icahn's Stock Portfolio
The article discusses Carl Icahn's stock portfolio, focusing on Bausch Health Companies Inc. Amidst controversies, Icahn's high-risk strategy has seen success with an annual return of 14%. BHC, a top ...
By Yahoo! Finance | 3 hours ago
